Harmony Biosciences Holdings, Inc. (HRMY)
NASDAQ: HRMY · Real-Time Price · USD
38.41
-0.34 (-0.88%)
Aug 7, 2026, 4:00 PM EDT - Market closed
HRMY Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 181.27 | 158.69 | 145.49 | 128.85 | 181.47 | 34.6 |
Depreciation & Amortization | 25.34 | 25.34 | 24.11 | 24.36 | 23.39 | 18.84 |
Stock-Based Compensation | 40.9 | 44.9 | 42.6 | 31.71 | 26.17 | 15.66 |
Other Adjustments | 48.78 | 27.47 | 14.94 | -0.57 | -82.46 | 28.83 |
Change in Receivables | -18.01 | -13.75 | -8.89 | -19.4 | -19.9 | -12.67 |
Changes in Inventories | -0.26 | 1.84 | -1.84 | -1.07 | 0.14 | -0.61 |
Changes in Accounts Payable | -6.62 | 3.95 | -5.38 | 8.95 | 2.79 | -1.56 |
Changes in Accrued Expenses | - | - | - | - | - | 17.26 |
Changes in Other Operating Activities | 83.69 | 99.78 | 8.79 | 46.55 | 12.87 | -1.8 |
Operating Cash Flow | 355.08 | 348.2 | 219.82 | 219.39 | 144.47 | 98.56 |
Operating Cash Flow Growth | 36.90% | 58.40% | 0.20% | 51.86% | 46.58% | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -0.18 | -0.31 | -1.15 | -0.31 | -0.17 | -0.3 |
Purchases of Investments | -374.65 | -86.15 | -105.29 | -127.47 | -110.73 | - |
Proceeds from Sale of Investments | 88.51 | 81.06 | 98.53 | 118.31 | 9.07 | - |
Cash Acquisitions | - | - | -33.07 | -36.97 | - | - |
Other Investing Activities | -32 | -34.25 | -26.5 | - | -40 | -100 |
Investing Cash Flow | -337.57 | -39.65 | -67.48 | -46.44 | -141.83 | -100.3 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Issued | - | - | - | 200 | - | 200 |
Long-Term Debt Repaid | -18.75 | -16.25 | -15 | -201.25 | -2 | -200.5 |
Net Long-Term Debt Issued (Repaid) | -18.75 | -16.25 | -15 | -1.25 | -2 | -0.5 |
Issuance of Common Stock | 9.27 | 10.21 | 6.5 | 5.06 | 8.84 | 39.37 |
Repurchase of Common Stock | - | - | - | -100 | - | - |
Net Common Stock Issued (Repurchased) | 9.27 | 10.21 | 6.5 | -94.95 | 8.84 | 39.37 |
Other Financing Activities | -4.3 | -3 | -2.5 | -9.36 | - | -30.45 |
Financing Cash Flow | -13.79 | -9.05 | -11 | -105.55 | 6.84 | 7.42 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Cash Flow | 3.72 | 299.5 | 141.34 | 67.4 | 9.48 | 5.68 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 354.9 | 347.89 | 218.67 | 219.08 | 144.29 | 98.26 |
Free Cash Flow Growth | 37.17% | 59.09% | -0.19% | 51.82% | 46.85% | - |
FCF Margin | 36.97% | 40.06% | 30.59% | 37.64% | 32.95% | 32.17% |
Free Cash Flow Per Share | 6.04 | 5.94 | 3.78 | 3.63 | 2.36 | 1.66 |
Levered Free Cash Flow | 264.49 | 273.03 | 155.02 | 206.09 | 218.47 | 65.94 |
Unlevered Free Cash Flow | 275.31 | 284.42 | 169.28 | 221.18 | 247.34 | 112.75 |